NASDAQ:SHPG - Shire News Headlines

Sign in or create an account to add this stock to your watchlist.
$170.12 -2.63 (-1.52 %)
(As of 12/11/2018 06:51 AM ET)
Previous Close$172.75
Today's Range$168.66 - $171.14
52-Week Range$123.73 - $182.47
Volume2.26 million shs
Average Volume1.70 million shs
Market Capitalization$52.74 billion
P/E Ratio11.25
Dividend Yield0.19%
Beta1.01

Headlines

Shire (NASDAQ SHPG) News Headlines

Source:
DateHeadline
Elliott Capital Advisors, LP: Form 8.3 - Shire PLC - GlobeNewswireElliott Capital Advisors, LP: Form 8.3 - Shire PLC - GlobeNewswire
globenewswire.com - December 7 at 5:43 PM
Takeda Shareholders Approve Shire (SHPG) AcquisitionTakeda Shareholders Approve Shire (SHPG) Acquisition
www.streetinsider.com - December 7 at 8:15 AM
Holding(s) in Company London Stock Exchange:SHP - GlobeNewswireHolding(s) in Company London Stock Exchange:SHP - GlobeNewswire
globenewswire.com - December 6 at 5:34 PM
Davidson Kempner Capital Management LP : Form 8.3 - Shire Plc - GlobeNewswireDavidson Kempner Capital Management LP : Form 8.3 - Shire Plc - GlobeNewswire
globenewswire.com - December 6 at 5:34 PM
Takeda Wins Shareholder Approval for $62 Billion Shire Deal - BloombergTakeda Wins Shareholder Approval for $62 Billion Shire Deal - Bloomberg
www.bloomberg.com - December 6 at 5:34 PM
Shire PLC (SHPG) Receives Consensus Recommendation of "Hold" from BrokeragesShire PLC (SHPG) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 6 at 1:42 PM
Hedge Funds Are Betting On Shire PLC (NASDAQ:SHPG)Hedge Funds Are Betting On Shire PLC (NASDAQ:SHPG)
finance.yahoo.com - December 6 at 8:20 AM
Shire PLC (SHPG) Forecasted to Earn FY2018 Earnings of $15.15 Per ShareShire PLC (SHPG) Forecasted to Earn FY2018 Earnings of $15.15 Per Share
www.americanbankingnews.com - December 6 at 7:26 AM
Shire (SHPG) Receiving Neutral Media Coverage, InfoTrie ReportsShire (SHPG) Receiving Neutral Media Coverage, InfoTrie Reports
www.americanbankingnews.com - December 6 at 7:16 AM
Takeda, Shire shareholders approve $62B tie-upTakeda, Shire shareholders approve $62B tie-up
www.bizjournals.com - December 5 at 5:20 PM
Is the Options Market Predicting a Spike in Shire (SHPG) Stock?Is the Options Market Predicting a Spike in Shire (SHPG) Stock?
www.msn.com - December 5 at 5:20 PM
Shire (SHPG) Rating Reiterated by B. RileyShire (SHPG) Rating Reiterated by B. Riley
www.americanbankingnews.com - December 5 at 11:37 AM
Takeda shareholders OK £46B takeout of ShireTakeda shareholders OK £46B takeout of Shire
seekingalpha.com - December 5 at 8:13 AM
[$$] Takeda wins shareholder approval for £46bn Shire acquisition[$$] Takeda wins shareholder approval for £46bn Shire acquisition
finance.yahoo.com - December 5 at 8:13 AM
Takeda's Long Battle for $62 Billion Shire Deal Gets VictoryTakeda's Long Battle for $62 Billion Shire Deal Gets Victory
finance.yahoo.com - December 5 at 8:13 AM
Takeda shareholders approve $62B deal to buy ShireTakeda shareholders approve $62B deal to buy Shire
finance.yahoo.com - December 5 at 8:13 AM
Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia AInitial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A
feeds.benzinga.com - December 1 at 2:11 PM
Shire (SHPG) Receives Coverage Optimism Rating of -1.50Shire (SHPG) Receives Coverage Optimism Rating of -1.50
www.americanbankingnews.com - December 1 at 5:57 AM
Shire receives European approval for TAKHZYRO subcutaneous injectionShire receives European approval for TAKHZYRO subcutaneous injection
seekingalpha.com - November 30 at 8:23 AM
Shire Granted Marketing Authorisation In EU For TAKHZYRO - Quick FactsShire Granted Marketing Authorisation In EU For TAKHZYRO - Quick Facts
www.nasdaq.com - November 30 at 8:23 AM
Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary AngioedemaShire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema
finance.yahoo.com - November 30 at 8:23 AM
Interesting SHPG Put And Call Options For January 2019Interesting SHPG Put And Call Options For January 2019
www.nasdaq.com - November 29 at 5:48 PM
Shire Sees Unusually High Options Volume (SHPG)Shire Sees Unusually High Options Volume (SHPG)
www.americanbankingnews.com - November 29 at 6:52 AM
Former Takeda chief not on board with Shire dealFormer Takeda chief not on board with Shire deal
seekingalpha.com - November 27 at 5:23 PM
Form 8 (DD) - Shire plcForm 8 (DD) - Shire plc
finance.yahoo.com - November 26 at 8:12 AM
Advisory firms back Takedas Shire buyAdvisory firms back Takeda's Shire buy
seekingalpha.com - November 20 at 5:23 PM
EU approves Takedas takeover of Shire with divestment conditionEU approves Takeda's takeover of Shire with divestment condition
seekingalpha.com - November 20 at 5:23 PM
Tracking John Paulsons Paulson & Company Portfolio - Q3 2018 UpdateTracking John Paulson's Paulson & Company Portfolio - Q3 2018 Update
seekingalpha.com - November 20 at 8:14 AM
Shire plc: Shire Announces New HELP Study Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific MeetingShire plc: Shire Announces New HELP Study Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting
www.finanznachrichten.de - November 16 at 8:13 AM
Shire Plc Reports Promising Data From HELP Extension Study With LanadelumabShire Plc Reports Promising Data From HELP Extension Study With Lanadelumab
www.nasdaq.com - November 16 at 8:13 AM
Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific MeetingShire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting
finance.yahoo.com - November 16 at 8:13 AM
Shire presents new late-stage data on HAE med lanadelumabShire presents new late-stage data on HAE med lanadelumab
seekingalpha.com - November 16 at 8:13 AM
[$$] Takeda dissident investors make last push to block Shire deal[$$] Takeda dissident investors make last push to block Shire deal
finance.yahoo.com - November 16 at 8:13 AM
Form 8.3 - SHIRE PLC AMENDMENTForm 8.3 - SHIRE PLC AMENDMENT
www.businesswire.com - November 15 at 5:29 PM
Merger Updates: B.Riley/magicJack Brought 7%+ In A Month. A Few New Deals.Merger Updates: B.Riley/magicJack Brought 7%+ In A Month. A Few New Deals.
seekingalpha.com - November 14 at 8:13 AM
Shires Filing Accepted by FDA for Gattexs Label ExpansionShire's Filing Accepted by FDA for Gattex's Label Expansion
www.zacks.com - November 14 at 8:13 AM
Shire: FDA To Review SNDA To Extend Indication Of GATTEX - Quick FactsShire: FDA To Review SNDA To Extend Indication Of GATTEX - Quick Facts
www.nasdaq.com - November 13 at 8:13 AM
Shire (SHPG) Reports FDA Accepted Filing sNDA for GATTEX for Children with Short Bowel SyndromeShire (SHPG) Reports FDA Accepted Filing sNDA for GATTEX for Children with Short Bowel Syndrome
www.streetinsider.com - November 13 at 8:13 AM
U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide ) for Children with Short Bowel SyndromeU.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide ) for Children with Short Bowel Syndrome
finance.yahoo.com - November 13 at 8:13 AM
Tracking David Abrams Abrams Capital Management Portfolio - Q3 2018 UpdateTracking David Abrams' Abrams Capital Management Portfolio - Q3 2018 Update
seekingalpha.com - November 12 at 8:18 AM
Takeda sets target date to close $62B Shire dealTakeda sets target date to close $62B Shire deal
seekingalpha.com - November 12 at 8:18 AM
[$$] Takeda sets date for shareholder vote on £46bn Shire deal[$$] Takeda sets date for shareholder vote on £46bn Shire deal
finance.yahoo.com - November 12 at 8:18 AM
Takeda sets vote date, aims to close $62 billion Shire deal on January 8Takeda sets vote date, aims to close $62 billion Shire deal on January 8
finance.yahoo.com - November 12 at 8:18 AM
Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8
finance.yahoo.com - November 12 at 8:18 AM
Takeda-Shire tie-up poised for thumbs-up in EuropeTakeda-Shire tie-up poised for thumbs-up in Europe
seekingalpha.com - November 9 at 5:39 PM
Shire's (SHPG) Earnings, Revenues Miss Estimates in Q3Shire's (SHPG) Earnings, Revenues Miss Estimates in Q3
finance.yahoo.com - November 3 at 8:17 AM
Shires (SHPG) Earnings, Revenues Miss Estimates in Q3Shire's (SHPG) Earnings, Revenues Miss Estimates in Q3
www.zacks.com - November 2 at 5:29 PM
Shire Q3 revenues up 5%; non-GAAP EPS down 5%; loweres guidanceShire Q3 revenues up 5%; non-GAAP EPS down 5%; loweres guidance
seekingalpha.com - November 1 at 6:09 PM
Takeda proposes sale of Shire drug to gain European approvalTakeda proposes sale of Shire drug to gain European approval
finance.yahoo.com - October 29 at 6:46 AM
Takeda offers to divest Shire IBD candidate to satisfy European regulators on mergerTakeda offers to divest Shire IBD candidate to satisfy European regulators on merger
seekingalpha.com - October 26 at 5:37 PM
This page was last updated on 12/11/2018 by MarketBeat.com Staff

Featured Article: Debt-To-Equity Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel